Iteos Therapeutics earnings were -$130.8M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest ITOS earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$34.6M, down 20.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ITOS reported annual earnings of -$134.4M, with 19.3% growth. The next ITOS earnings date is May 8, 2025.
What were Iteos Therapeutics's earnings last quarter?
On ITOS's earnings call on Invalid Date, Iteos Therapeutics (NASDAQ: ITOS) reported Q1 2025 earnings per share (EPS) of -$0.80, up 25.23% year over year. Total ITOS earnings for the quarter were -$34.61 million. In the same quarter last year, Iteos Therapeutics's earnings per share (EPS) was -$1.07.
The next ITOS earnings date is Invalid Date. Add ITOS to your watchlist to be reminded of Iteos Therapeutics's next earnings date.
Is Iteos Therapeutics profitable or losing money?
As of the last Iteos Therapeutics earnings report, Iteos Therapeutics is currently losing money. Iteos Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$130.81 million, a 3.32% decrease year over year.
What was ITOS's earnings growth in the past year?
As of Iteos Therapeutics's earnings date in Invalid Date, Iteos Therapeutics's earnings has grown year over year. ITOS earnings in the past year totalled -$130.81 million.
What are Iteos Therapeutics's earnings expectations?
The current EPS estimate for Iteos Therapeutics's earnings report in Invalid Date is -$0.90.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.